Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns
Study 126 cards on 30 common drug classes: mechanisms, qualified generic-name patterns, common uses, and major safety concepts for nursing and introductory health science.
Mayelana naleli qoqo
Build a durable pharmacology map with 126 independently authored cards. Six prerequisites define drug classes, mechanisms, agonism, antagonism, inhibition, and how to treat generic-name stems as fallible clues. The remaining 120 cards cover 30 common classes through four separate retrieval directions: class → core mechanism; qualified pattern or representative generics → class; class → common use; and class → major safety concept.
The deck deliberately excludes dosing, prescribing, patient-specific guidance, administration or hold parameters, exhaustive contraindications and interactions, monitoring protocols, brand names, official questions, and clinical cases. Generic-name patterns are clues, never universal rules. Use this deck for study—not clinical decision-making.
Ordering supports learning: prerequisites come first, then five spiral blocks mix six broad topic groups. Same-class variants stay at least three unrelated cards apart, alternating mechanism, recognition, common-use, and safety recall instead of forming predictable runs.
Open Study Contributor independently authored this standalone deck from common pharmacology knowledge checked against WHO, FDA, and NIH/NCBI sources. Organization names identify sources only; no affiliation or endorsement is claimed.
Amakhadi akuleli qoqo
Ikhadi 1
Umbuzo
What is a drug class?
Impendulo
A group of drugs linked by a shared mechanism, target, structure, therapeutic use, or a combination of these features.
Ikhadi 2
Umbuzo
What does mechanism of action mean?
Impendulo
How a drug produces its effects at a molecular, cellular, or physiological target.
Ikhadi 3
Umbuzo
What is a receptor agonist?
Impendulo
A drug that binds to a receptor and activates it to produce a response.
Ikhadi 4
Umbuzo
What is a receptor antagonist?
Impendulo
A drug that binds to a receptor and blocks or reduces activation by an agonist.
Ikhadi 5
Umbuzo
What does it mean when a drug inhibits an enzyme or transporter?
Impendulo
It reduces that protein's activity, changing the movement or conversion of its usual substrates.
Ikhadi 6
Umbuzo
How should generic-name stems be used to recognize drug classes?
Impendulo
As clues, not universal rules. Confirm the actual drug because exceptions and overlapping stems exist.
Ikhadi 7
Umbuzo
ACE inhibitors: core mechanism?
Impendulo
They inhibit angiotensin-converting enzyme, reducing angiotensin II and aldosterone while increasing bradykinin.
Ikhadi 8
Umbuzo
SSRIs: core mechanism?
Impendulo
They inhibit the serotonin transporter, increasing serotonin signaling in the synaptic cleft.
Ikhadi 9
Umbuzo
Biguanides: core mechanism?
Impendulo
Metformin mainly reduces hepatic glucose production and improves insulin sensitivity without directly stimulating insulin release.
Ikhadi 10
Umbuzo
Penicillins: core mechanism?
Impendulo
Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.
Ikhadi 11
Umbuzo
Which class is often suggested by the ending -pril?
Impendulo
ACE inhibitors. Examples include lisinopril and enalapril, but a name stem is only a clue.
Ikhadi 12
Umbuzo
Proton-pump inhibitors: core mechanism?
Impendulo
They inhibit the H+/K+ ATPase proton pump in gastric parietal cells, strongly reducing acid secretion.
Ikhadi 13
Umbuzo
SSRIs: common uses?
Impendulo
Depression and several anxiety-related disorders; the approved indications differ by agent.
Ikhadi 14
Umbuzo
NSAIDs: core mechanism?
Impendulo
They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis.
Ikhadi 15
Umbuzo
Biguanides: major safety concepts?
Impendulo
Gastrointestinal effects are common; vitamin B12 can fall with long use, and lactic acidosis is rare but serious.
Ikhadi 16
Umbuzo
Which class is often suggested by the ending -cillin?
Impendulo
Penicillins, such as amoxicillin and piperacillin. The stem does not describe spectrum or resistance.
Ikhadi 17
Umbuzo
ACE inhibitors: common uses?
Impendulo
Hypertension and selected heart-failure, post-myocardial-infarction, and kidney-protection indications.
Ikhadi 18
Umbuzo
Proton-pump inhibitors: major safety concepts?
Impendulo
Possible concerns include hypomagnesemia and enteric infection risk. Many other long-term links are observational rather than proven causal effects.
Ikhadi 19
Umbuzo
Which class is often suggested by -oxetine or -opram?
Impendulo
SSRIs, but not universally. Sertraline and fluvoxamine are exceptions, and some stems overlap other classes.
Ikhadi 20
Umbuzo
NSAIDs: common uses?
Impendulo
Pain, inflammation, and fever; individual agents also have more specific uses.
Ikhadi 21
Umbuzo
Metformin belongs to which drug class?
Impendulo
Biguanides. Metformin is the main widely used member, so there is no useful class-wide suffix rule.
Ikhadi 22
Umbuzo
Penicillins: major safety concepts?
Impendulo
Hypersensitivity can range from rash to anaphylaxis; diarrhea and antibiotic-associated colitis are additional concerns.
Ikhadi 23
Umbuzo
ACE inhibitors: major safety concepts?
Impendulo
Cough, hyperkalemia, kidney-function changes, angioedema, and fetal harm are major class concerns.
Ikhadi 24
Umbuzo
Proton-pump inhibitors: common uses?
Impendulo
Acid-related disorders such as GERD, erosive esophagitis, and peptic-ulcer disease.
Ikhadi 25
Umbuzo
SSRIs: major safety concepts?
Impendulo
Serotonin syndrome, bleeding and hyponatremia risks, sexual dysfunction, and the antidepressant suicidality warning for younger people.
Ikhadi 26
Umbuzo
Ibuprofen, naproxen, and ketorolac belong to which class?
Impendulo
NSAIDs. The class has no single reliable generic-name suffix.
Ikhadi 27
Umbuzo
Biguanides: common use?
Impendulo
Type 2 diabetes.
Ikhadi 28
Umbuzo
Penicillins: common use?
Impendulo
Treatment of susceptible bacterial infections; the spectrum differs substantially among individual penicillins.
Ikhadi 29
Umbuzo
Which class is often suggested by the ending -prazole?
Impendulo
Proton-pump inhibitors, such as omeprazole and pantoprazole. Confirm the individual drug.
Ikhadi 30
Umbuzo
NSAIDs: major safety concepts?
Impendulo
Gastrointestinal bleeding, kidney injury, fluid retention, and cardiovascular events are key risks; FDA also warns about use from about 20 weeks of pregnancy.
Ikhadi 31
Umbuzo
Sulfonylureas: core mechanism?
Impendulo
They close ATP-sensitive potassium channels in pancreatic beta cells, triggering insulin release even when glucose is not high.
Ikhadi 32
Umbuzo
H2 blockers: core mechanism?
Impendulo
They competitively block histamine H2 receptors on gastric parietal cells, reducing acid secretion.
Ikhadi 33
Umbuzo
SNRIs: core mechanism?
Impendulo
They inhibit serotonin and norepinephrine reuptake transporters, increasing both transmitters in synapses.
Ikhadi 34
Umbuzo
Opioid analgesics: core mechanism?
Impendulo
They activate opioid receptors; many important analgesic effects and toxicities are mediated through mu receptors.
Ikhadi 35
Umbuzo
Glipizide, glyburide, and glimepiride belong to which class?
Impendulo
Sulfonylureas. Their names offer clues, but the broad ending -ide is not class-specific.
Ikhadi 36
Umbuzo
ARBs: core mechanism?
Impendulo
They block angiotensin II at AT1 receptors, reducing vasoconstriction and aldosterone effects.
Ikhadi 37
Umbuzo
H2 blockers: common uses?
Impendulo
Acid-related disorders such as heartburn, GERD, and gastric or duodenal ulcers.
Ikhadi 38
Umbuzo
Cephalosporins: core mechanism?
Impendulo
Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.
Ikhadi 39
Umbuzo
SNRIs: major safety concepts?
Impendulo
Serotonin syndrome, blood-pressure increases, discontinuation symptoms, and the antidepressant suicidality warning for younger people.
Ikhadi 40
Umbuzo
Morphine, oxycodone, and fentanyl belong to which broad class?
Impendulo
Opioid analgesics. The class has no single reliable generic-name suffix.
Ikhadi 41
Umbuzo
Sulfonylureas: common use?
Impendulo
Type 2 diabetes when increasing pancreatic insulin release is appropriate.
Ikhadi 42
Umbuzo
ARBs: major safety concepts?
Impendulo
Hyperkalemia, hypotension, kidney-function changes, and fetal harm are major concerns; cough is less common than with ACE inhibitors.
Ikhadi 43
Umbuzo
Which class is often suggested by the ending -tidine?
Impendulo
H2 receptor blockers, such as famotidine and cimetidine. Confirm the individual drug.
Ikhadi 44
Umbuzo
Cephalosporins: common use?
Impendulo
Treatment of susceptible bacterial infections; antibacterial spectrum varies widely by agent and generation.
Ikhadi 45
Umbuzo
Which name endings can suggest an SNRI?
Impendulo
-faxine or sometimes -oxetine, but neither is decisive. The -oxetine ending also appears in some SSRIs.
Ikhadi 46
Umbuzo
Opioid analgesics: major safety concepts?
Impendulo
Respiratory depression, sedation, constipation, tolerance, dependence, and overdose; benzodiazepines and other depressants increase danger.
Ikhadi 47
Umbuzo
Sulfonylureas: major safety concepts?
Impendulo
Hypoglycemia and weight gain are the main class patterns, with risk differing among agents and clinical contexts.
Ikhadi 48
Umbuzo
ARBs: common uses?
Impendulo
Hypertension and selected heart-failure and kidney-protection indications.
Ikhadi 49
Umbuzo
H2 blockers: major safety concepts?
Impendulo
They are usually well tolerated, but confusion or other CNS effects can occur with reduced clearance; cimetidine has many interactions.
Ikhadi 50
Umbuzo
Which class is often suggested by cef- or ceph-?
Impendulo
Cephalosporins, such as cefazolin and cephalexin. The name does not reveal the full spectrum.
Ikhadi 51
Umbuzo
SNRIs: common uses?
Impendulo
Depression and anxiety disorders; selected agents also treat neuropathic pain or fibromyalgia.
Ikhadi 52
Umbuzo
Opioid analgesics: common uses?
Impendulo
Analgesia for selected severe pain and perioperative settings; individual opioids also have other specific uses.
Ikhadi 53
Umbuzo
Which class is often suggested by the ending -sartan?
Impendulo
Angiotensin II receptor blockers, or ARBs. Examples include losartan and valsartan.
Ikhadi 54
Umbuzo
Cephalosporins: major safety concepts?
Impendulo
Hypersensitivity and antibiotic-associated diarrhea are important; penicillin cross-reactivity depends largely on similar side chains.
Ikhadi 55
Umbuzo
Beta2 agonists: core mechanism?
Impendulo
They activate beta2 receptors, increasing cAMP and relaxing airway smooth muscle.
Ikhadi 56
Umbuzo
Beta blockers: core mechanism?
Impendulo
They antagonize beta-adrenergic receptors; beta1 blockade can reduce heart rate, contractility, and renin release.
Ikhadi 57
Umbuzo
Systemic corticosteroids: core mechanism?
Impendulo
They bind intracellular glucocorticoid receptors and alter gene transcription, reducing inflammatory and immune signaling.
Ikhadi 58
Umbuzo
Benzodiazepines: core mechanism?
Impendulo
They positively modulate GABA-A receptors, increasing the frequency of chloride-channel opening when GABA is present.
Ikhadi 59
Umbuzo
Which class is often suggested by the ending -terol?
Impendulo
Beta2 agonist bronchodilators, such as formoterol and salmeterol. Albuterol is a familiar exception.
Ikhadi 60
Umbuzo
Macrolides: core mechanism?
Impendulo
They bind the bacterial 50S ribosomal subunit and inhibit protein synthesis.
Ikhadi 61
Umbuzo
Beta blockers: common uses?
Impendulo
Selected cardiovascular conditions such as arrhythmias, ischemic heart disease, heart failure, and hypertension; some agents have noncardiac uses.
Ikhadi 62
Umbuzo
GLP-1 receptor agonists: core mechanism?
Impendulo
They activate GLP-1 receptors, increasing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying.
Ikhadi 63
Umbuzo
Systemic corticosteroids: major safety concepts?
Impendulo
Infection, hyperglycemia, osteoporosis, and hypothalamic-pituitary-adrenal suppression; risks rise with systemic exposure and duration.
amakhadi angu-126
Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns
Funda leli qoqo mahhalaI-Nibomo iyavuleka ukuze uqale ukufunda.
Ikhadi 64
Umbuzo
Which endings often suggest a benzodiazepine?
Impendulo
-azepam or -azolam, as in diazepam or midazolam. Not every sedative with a similar ending belongs to this class.
Ikhadi 65
Umbuzo
Beta2 agonists: common use?
Impendulo
Bronchodilation in asthma or COPD regimens; short- and long-acting agents play different roles.
Ikhadi 66
Umbuzo
Macrolides: major safety concepts?
Impendulo
Gastrointestinal effects, QT prolongation, and clinically important interactions that vary by agent.
Ikhadi 67
Umbuzo
Which class is often suggested by the ending -olol?
Impendulo
Beta blockers, such as metoprolol and propranolol. Receptor selectivity still varies by agent.
Ikhadi 68
Umbuzo
GLP-1 receptor agonists: common uses?
Impendulo
Type 2 diabetes; selected agents are also approved for chronic weight management and cardiovascular-risk reduction.
Ikhadi 69
Umbuzo
Which patterns often suggest a systemic corticosteroid?
Impendulo
-sone or -olone, as in prednisone or prednisolone, but these endings are not unique to the class.
Ikhadi 70
Umbuzo
Benzodiazepines: major safety concepts?
Impendulo
Sedation, dependence and withdrawal, plus respiratory depression—especially with opioids, alcohol, or other CNS depressants.
Ikhadi 71
Umbuzo
Beta2 agonists: major safety concepts?
Impendulo
Tremor, palpitations or tachycardia, hypokalemia, and rare paradoxical bronchospasm.
Ikhadi 72
Umbuzo
Macrolides: common use?
Impendulo
Treatment of selected susceptible bacterial infections, including some respiratory and atypical pathogens.
Ikhadi 73
Umbuzo
Beta blockers: major safety concepts?
Impendulo
Bradycardia and hypotension; nonselective agents can cause bronchospasm, and the class can mask adrenergic signs of hypoglycemia.
Ikhadi 74
Umbuzo
Which class is often suggested by -glutide?
Impendulo
GLP-1 receptor agonists, such as semaglutide and liraglutide. Exenatide and lixisenatide show the pattern is not universal.
Ikhadi 75
Umbuzo
Systemic corticosteroids: common uses?
Impendulo
Inflammatory, allergic, and autoimmune disorders, with the route and agent chosen for the condition.
Ikhadi 76
Umbuzo
Benzodiazepines: common uses?
Impendulo
Anxiety, seizures, procedural sedation, or alcohol withdrawal, depending on the agent and setting.
Ikhadi 77
Umbuzo
Which class is often suggested by the ending -thromycin?
Impendulo
Macrolide antibiotics, such as azithromycin and clarithromycin. Confirm the individual agent.
Ikhadi 78
Umbuzo
GLP-1 receptor agonists: major safety concepts?
Impendulo
Gastrointestinal effects are common; gallbladder disease and pancreatitis are warnings, and some labels warn about thyroid C-cell tumors.
Ikhadi 79
Umbuzo
Second-generation antipsychotics: core mechanism?
Impendulo
Most modulate dopamine D2 and serotonin 5-HT2A signaling, but receptor profiles vary substantially by agent.
Ikhadi 80
Umbuzo
Tetracyclines: core mechanism?
Impendulo
They bind the bacterial 30S ribosomal subunit and inhibit protein synthesis.
Ikhadi 81
Umbuzo
Dihydropyridine calcium-channel blockers: core mechanism?
Impendulo
They block L-type calcium channels mainly in vascular smooth muscle, causing arteriolar relaxation.
Ikhadi 82
Umbuzo
Inhaled antimuscarinics: core mechanism?
Impendulo
They block airway muscarinic receptors, reducing vagal bronchoconstriction and promoting bronchodilation.
Ikhadi 83
Umbuzo
Which endings often suggest a second-generation antipsychotic?
Impendulo
-apine or -idone often appear, but many members use other endings and the stems are not class-specific.
Ikhadi 84
Umbuzo
SGLT2 inhibitors: core mechanism?
Impendulo
They inhibit renal sodium-glucose cotransporter 2, increasing urinary glucose and sodium excretion.
Ikhadi 85
Umbuzo
Tetracyclines: common uses?
Impendulo
Selected susceptible bacterial infections and, for some agents, acne or rosacea.
Ikhadi 86
Umbuzo
Bisphosphonates: core mechanism?
Impendulo
They bind bone mineral and inhibit osteoclast-mediated bone resorption.
Ikhadi 87
Umbuzo
Dihydropyridine calcium-channel blockers: major safety concepts?
Impendulo
Peripheral edema, flushing, headache, dizziness, and hypotension are characteristic patterns.
Ikhadi 88
Umbuzo
Which class is often suggested by the ending -tropium?
Impendulo
Inhaled antimuscarinic bronchodilators, such as ipratropium and tiotropium. Several class members use other endings.
Ikhadi 89
Umbuzo
Second-generation antipsychotics: common uses?
Impendulo
Schizophrenia and selected bipolar or other psychiatric indications; approvals differ by agent.
Ikhadi 90
Umbuzo
SGLT2 inhibitors: major safety concepts?
Impendulo
Genital infections, volume depletion, ketoacidosis, and rare necrotizing infection of the perineum.
Ikhadi 91
Umbuzo
Which class is often suggested by the ending -cycline?
Impendulo
Tetracycline antibiotics, such as doxycycline and minocycline. Confirm the individual drug.
Ikhadi 92
Umbuzo
Bisphosphonates: common uses?
Impendulo
Osteoporosis and selected disorders with excessive bone resorption, including Paget disease or malignancy-related bone disease.
Ikhadi 93
Umbuzo
Which class is often suggested by the ending -dipine?
Impendulo
Dihydropyridine calcium-channel blockers, such as amlodipine and nifedipine.
Ikhadi 94
Umbuzo
Inhaled antimuscarinics: major safety concepts?
Impendulo
Dry mouth, urinary retention, tachycardia, and eye exposure that may worsen narrow-angle glaucoma.
Ikhadi 95
Umbuzo
Second-generation antipsychotics: major safety concepts?
Impendulo
Metabolic effects, movement disorders, QT effects, and neuroleptic malignant syndrome; labels warn about increased mortality in elderly patients with dementia-related psychosis.
Ikhadi 96
Umbuzo
SGLT2 inhibitors: common uses?
Impendulo
Type 2 diabetes; selected agents also treat heart failure or chronic kidney disease.
Ikhadi 97
Umbuzo
Tetracyclines: major safety concepts?
Impendulo
Gastrointestinal or esophageal irritation, photosensitivity, and effects on developing teeth and bone are key patterns.
Ikhadi 98
Umbuzo
Which class is often suggested by the ending -dronate?
Impendulo
Bisphosphonates, such as alendronate and risedronate. Confirm the individual agent and formulation.
Ikhadi 99
Umbuzo
Dihydropyridine calcium-channel blockers: common uses?
Impendulo
Hypertension and angina, using vascular smooth-muscle relaxation to reduce arterial tone.
Ikhadi 100
Umbuzo
Inhaled antimuscarinics: common use?
Impendulo
Maintenance bronchodilation, especially in COPD; selected agents also serve as add-on asthma therapy.
Ikhadi 101
Umbuzo
Which class is often suggested by the ending -gliflozin?
Impendulo
SGLT2 inhibitors, such as empagliflozin and dapagliflozin.
Ikhadi 102
Umbuzo
Bisphosphonates: major safety concepts?
Impendulo
Upper-GI irritation with oral agents, hypocalcemia, and rare osteonecrosis of the jaw or atypical femur fracture.
Ikhadi 103
Umbuzo
TNF inhibitors: core mechanism?
Impendulo
They neutralize tumor necrosis factor signaling, reducing downstream inflammation.
Ikhadi 104
Umbuzo
DPP-4 inhibitors: core mechanism?
Impendulo
They inhibit DPP-4, prolonging endogenous incretin activity and increasing glucose-dependent insulin release.
Ikhadi 105
Umbuzo
Inhaled corticosteroids: core mechanism?
Impendulo
They activate glucocorticoid receptors in airway cells, reducing inflammatory gene expression and airway inflammation.
Ikhadi 106
Umbuzo
Statins: core mechanism?
Impendulo
They inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing hepatic LDL-receptor activity.
Ikhadi 107
Umbuzo
Adalimumab, infliximab, and etanercept belong to which class?
Impendulo
TNF inhibitors. The class has no single specific shared suffix: -mab is broad, and etanercept ends in -cept.
Ikhadi 108
Umbuzo
Triptans: core mechanism?
Impendulo
They activate serotonin 5-HT1B/1D receptors, reducing trigeminal signaling and causing cranial vasoconstriction.
Ikhadi 109
Umbuzo
DPP-4 inhibitors: common use?
Impendulo
Type 2 diabetes, using enhanced endogenous incretin signaling to improve glucose-dependent insulin release.
Ikhadi 110
Umbuzo
Fluoroquinolones: core mechanism?
Impendulo
They inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication.
Ikhadi 111
Umbuzo
Inhaled corticosteroids: major safety concepts?
Impendulo
Oral candidiasis and dysphonia are important local effects; systemic effects become more relevant with higher exposure.
Ikhadi 112
Umbuzo
Which class is suggested by the ending -statin?
Impendulo
HMG-CoA reductase inhibitors, or statins, such as atorvastatin and rosuvastatin.
Ikhadi 113
Umbuzo
TNF inhibitors: common uses?
Impendulo
Selected autoimmune inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis-related conditions.
Ikhadi 114
Umbuzo
Triptans: major safety concepts?
Impendulo
Vasoconstrictive risk in coronary, cerebrovascular, or peripheral vascular disease, plus tingling, flushing, or chest pressure called triptan sensations.
Ikhadi 115
Umbuzo
Which class is suggested by the ending -gliptin?
Impendulo
DPP-4 inhibitors, such as sitagliptin and linagliptin.
Ikhadi 116
Umbuzo
Fluoroquinolones: common use?
Impendulo
Selected serious or resistant bacterial infections when their spectrum and risk profile fit the infection.
Ikhadi 117
Umbuzo
Which patterns often suggest an inhaled corticosteroid?
Impendulo
-sonide or -sone often appear, as in budesonide or fluticasone, but these endings are not class-specific.
Ikhadi 118
Umbuzo
Statins: major safety concepts?
Impendulo
Muscle symptoms and rare rhabdomyolysis or liver injury; pregnancy is a major risk context, although FDA no longer applies a blanket class contraindication.
Ikhadi 119
Umbuzo
TNF inhibitors: major safety concepts?
Impendulo
Serious infections and reactivation of tuberculosis or hepatitis B are central concerns; other warnings vary by agent.
Ikhadi 120
Umbuzo
Triptans: common use?
Impendulo
Acute treatment of migraine attacks; they are not general-purpose analgesics or routine migraine preventives.
Ikhadi 121
Umbuzo
DPP-4 inhibitors: major safety concepts?
Impendulo
Severe joint pain and pancreatitis are warnings; some agents also carry a heart-failure warning.
Ikhadi 122
Umbuzo
Which class is suggested by the ending -floxacin?
Impendulo
Fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin.
Ikhadi 123
Umbuzo
Inhaled corticosteroids: common use?
Impendulo
Controller therapy for asthma and selected COPD regimens; they reduce inflammation rather than acting as standalone rescue bronchodilators.
Ikhadi 124
Umbuzo
Statins: common uses?
Impendulo
Lowering LDL cholesterol and reducing atherosclerotic cardiovascular risk.
Ikhadi 125
Umbuzo
Which class is suggested by the ending -triptan?
Impendulo
Triptan antimigraine agents, such as sumatriptan and rizatriptan.
Ikhadi 126
Umbuzo
Fluoroquinolones: major safety concepts?
Impendulo
Potentially disabling tendon, muscle, joint, nerve, and CNS effects, plus a rare risk of aortic aneurysm or rupture in susceptible people.
amakhadi angu-126
Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns
I-Nibomo iyavuleka ukuze uqale ukufunda.